Concept Life Sciences, a multi-disciplined contract research organisation, has officially opened its newly expanded integrated drug discovery facilities at its Chapel-en-le-Frith headquarters, establishing one of the UK’s largest drug discovery research sites.

Now employing 130 scientists, the expansion unites chemistry, ADMET and screening biology under one roof, significantly enhancing the company’s ability to deliver faster, more efficient and fully integrated drug discovery solutions, providing customers with a seamless pathway from concept to clinic.

Jonathan Critchley, chief financial officer, said the expansion strengthens the company’s ability to transform breakthrough science into viable, fundable and clinically impactful therapies, with bespoke approaches designed to help early-stage research companies overcome the challenges of drug discovery.

Jon Pearce MP for High Peak praised the development, highlighting its role in creating high-skilled, high-value jobs in the community while positioning the region at the forefront of pioneering work to develop life-changing therapies.

With enhanced capabilities spanning small molecules, biologics, peptides and cell and gene therapies, the site will enable faster development timelines, streamlined communication and improved success rates for early-stage innovations. This investment reflects Concept Life Sciences’ commitment to driving innovation in drug discovery and delivering transformative therapies that improve lives worldwide.